Logo image
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease
Journal article   Open access   Peer reviewed

Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease

Jacob E Simmering, Michael J Welsh, Lei Liu, Nandakumar S Narayanan and Anton Pottegård
JAMA neurology, Vol.78(4), pp.407-413
04/01/2021
DOI: 10.1001/jamaneurol.2020.5157
PMCID: PMC7851758
PMID: 33523098
url
https://doi.org/10.1001/jamaneurol.2020.5157View
Published (Version of record) Open Access

Abstract

This cohort study investigates whether use of terazosin, doxazosin, and alfuzosin is associated with a decreased risk of developing Parkinson disease compared with use of tamsulosin.
Online First Research Comments Original Investigation

Details

Metrics

Logo image